A trip to a trailblazing Pacific Northwest National Laboratory in Richmond reveals major implications for research.

Company executives said that the firm's recent purchases of Saga Diagnostics and PathAI will provide synergies throughout its oncology portfolio.

Emerging research suggests the state of the gut microbiome in early life is linked to colorectal cancer—and that both too ...

At-home FIT screening involves testing stool for amounts of blood too small to see, which can help to diagnose colon cancer earlier. This is important for improved treatment outcomes. While it is an ...

This important procedure doesn’t have to feel awkward or embarrassing. Here’s what to know to make it easier.

A new study suggests the rise of young colon cancer may be linked to a common weed killer. More evidence is needed to tie the herbicide definitively to young colon cancer. It's a first clue for what ...

Currently, clinical examination, imaging, colonoscopy, and carcinoembryonic antigen (CEA) are monitored in surveillance to detect recurrence. Sensitivity of CEA as a tumor marker is limited (ranging ...

The AI-assisted colonoscopy era was associated with a 47% reduction in interval colorectal cancer incidence and higher ...

A first-in-human (FIH), phase 1/2, dose-escalation, dose-optimization, and dose-expansion study of PARP1-selective inhibitor IMP1734 in participants with advanced solid tumors. Nivolumab (NIVO) plus ...